Some kind of Wyckoff accumulationThe pattern seems taken from the wyckoff accumulation book. You be the judge.
Next report date
Report period
Q4 2024
EPS estimate
0.05EUR
Revenue estimate
126.80 MEUR
−0.14EUR
−8.51 MEUR
410.37 MEUR
93.46 M
About Accuray Incorporated
Sector
Industry
CEO
Suzanne C. Winter
Website
Headquarters
Madison
Employees (FY)
1.02 K
Founded
1990
Accuray, Inc. is a radiation oncology company, which engages in the development, manufacture, and sale of treatment solutions that include CyberKnife and Tomo Therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Madison, WI.
$ARAY the ascending triangle is now an upward channelWhat looks like a false breakout is turning into what could be an upward channel, Just shows why its better to scale in and out of positions. This way you scale in small and withstand any big swings and add on dips later. Still long and will add later.
$ARAY Attempting to break multiyear resistance (again)Weekly chart
I've posted this before but was stopped out and noticed consolidation was going to be much longer than expected. Reminder: ARAY has never had 4 consecutive earnings beats until these last 4 qtrs. Financials look better than ever.
$ARAY Attempting to break multiyear resistance. (Weekly Chart)Looking back at previous earnings announcements I don't think $ARAY has ever beat estimates for 3 or more quarters in a row. Currently it has beaten estimates for the past 4 consecutive qtrs. Its up 223% since its March lows and currently try to break a 5 year resistance level. Will be watching this
Accuray, Inc. Major Breakout Underway Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radi
$ARAY Accuray Inc Breakout Trade Setup
Potential for major trendline break-
Entry above $4.08
Target price $4.60 short term
$ARAY Accuray Inc On watch for Muli-year Trendline Breakout
On strong watch for a major breakout above long term downtrend.
Point of Control (POC Redline) also sits as major resistance.
Stock has rallied on the back of strong earnings.
Golden cross complete on MA's.
Potential targets on any break $4.70 - $5.00
$ARAY Accuray Inc On Breakout Watch
ARAY on watch for a major breakout today as a result
of positive earnings results.
Alert set for move above $3.20
First major target $3.42
Fibonacci Target $3.70
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of XEJ is 2.02 EUR — it has decreased by 0.98% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ACCURAY INC stocks are traded under the ticker XEJ.
ACCURAY INC is going to release the next earnings report on Aug 15, 2024. Keep track of upcoming events with our Earnings Calendar.
XEJ stock is 1.98% volatile and has beta coefficient of 1.38. Check out the list of the most volatile stocks — is ACCURAY INC there?
XEJ earnings for the last quarter are −0.09 EUR per share, whereas the estimation was −0.05 EUR resulting in a −95.95% surprise. The estimated earnings for the next quarter are −0.01 EUR per share. See more details about ACCURAY INC earnings.
ACCURAY INC revenue for the last quarter amounts to 97.16 M EUR despite the estimated figure of 96.65 M EUR. In the next quarter revenue is expected to reach 107.47 M EUR.
Yes, you can track ACCURAY INC financials in yearly and quarterly reports right on TradingView.
XEJ stock has fallen by 1.94% compared to the previous week, the month change is a 9.82% fall, over the last year ACCURAY INC has showed a 30.34% decrease.
XEJ net income for the last quarter is −8.72 M EUR, while the quarter before that showed −2.81 M EUR of net income which accounts for −210.35% change. Track more ACCURAY INC financial stats to get the full picture.
Today ACCURAY INC has the market capitalization of 197.14 M, it has decreased by 2.99% over the last week.
No, XEJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, XEJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACCURAY INC stock right from TradingView charts — choose your broker and connect to your account.
As of May 2, 2024, the company has 1.02 K employees. See our rating of the largest employees — is ACCURAY INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACCURAY INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACCURAY INC stock shows the strong sell signal. See more of ACCURAY INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ACCURAY INC future price: according to them, XEJ price has a max estimate of 12.07 EUR and a min estimate of 5.57 EUR. Read a more detailed ACCURAY INC forecast: see what analysts think of ACCURAY INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACCURAY INC EBITDA is 5.35 M EUR, and current EBITDA margin is 2.15%. See more stats in ACCURAY INC financial statements.